Developer docs
API playgroundTry for free, no card

Search company profiles

Bpifrance Large Venture

Full company profile

uuid00068rg

Namestring
Bpifrance Large Venture
Legal namestring
Bpifrance
Websiteurl
bpifrance.com
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Bpifrance Large Venture is a dedicated growth-stage venture capital fund operated by Bpifrance, the French public investment bank and sovereign fund wholly owned by the French State and Caisse des Dépôts. The fund invests equity and quasi-equity capital in highly innovative technology and life sciences companies, both listed and unlisted, that require large, late-stage tickets to scale internationally. It is documented with a €2.5 billion deployment size and pursues a horizontal strategy across deep tech, quantum, AI infrastructure, digital media, and biotech. Its product page explicitly positions it as the Growth arm of Bpifrance's investment continuum, providing anchor checks in private rounds, IPOs (IEVA Group on Euronext Growth Paris), and structured/SPAC transactions (Pasqal).

Short descriptiontext

Bpifrance Large Venture is a €2.5 billion growth-stage venture capital fund operated within Bpifrance, France's sovereign public investment bank. It provides equity and quasi-equity financing to highly innovative technology and life sciences companies via anchors in private rounds, IPOs, and SPAC transactions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMaisons-alfort, France
HQ citystring
Maisons-alfort
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
venture capital, growth equity, technology investment, life sciences investment, growth fund
Industry3 codes
1Growth Equity Fund-of-Funds
CodeFSANAGAEPrimaryYes
2Venture Growth / Recurring Revenue Credit Funds
CodeFSANAIAGPrimaryNo
3Large-Cap / Sponsor Finance Direct Lending
CodeFSANADAJPrimaryNo
NAICS code3 codes
  • Other Investment Pools and Funds5259
  • Portfolio Management and Investment Advice52394
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Growth Equity
Social media profiles2 records
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bpifrance Large Venture is a €2.5 billion Growth fund providing equity and quasi-equity financing to highly innovative Technology and Life Sciences companies (both listed and unlisted), active on international markets. The fund typically acts as anchor or lead investor in significant funding rounds, IPOs (such as IEVA Group on Euronext Growth Paris), and SPAC transactions (such as Pasqal's $2 billion deal), supporting companies with high growth potential that require substantial capital to scale.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bpifrance Large Venture is a single focused investment fund product — a €2.5 billion Growth fund managed by Bpifrance that targets highly innovative Technology & Life Sciences companies (both listed and unlisted). The fund provides equity and quasi-equity financing to support companies with strong growth potential, often acting as an anchor or lead investor in significant funding rounds. It is part of Bpifrance's broader continuum of investment solutions but represents a distinct, named fund product aimed at later-stage innovative companies seeking to scale.

Product and service1 record
1Bpifrance Large Venture Fund
CategoryVenture Capital / Growth Equity Fund
Description

A €2.5 billion Growth fund managed by Bpifrance that provides equity and quasi-equity investment to highly innovative Technology and Life Sciences companies (listed or unlisted) active on international markets, acting as anchor or lead investor in major funding rounds, IPOs, and SPAC transactions to support high-growth potential companies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German state-backed venture and growth capital investor (subsidiary of KfW Group) that anchors and funds German and European growth-stage technology companies. Most directly comparable as another sovereign-backed European growth fund of similar scale and mandate to Bpifrance Large Venture.

TypeDirect peer
Description

UK government-backed commercial subsidiary of the British Business Bank that invests in UK growth-stage venture and venture capital funds. Comparable as a state-backed growth capital provider focused on scaling innovative companies in a major European economy.

TypeDirect peer
Description

EQT's growth equity strategy invests in fast-growing, often technology-driven companies in the Nordic and broader European region with similar late-stage growth equity profile to Bpifrance Large Venture's mandate.

TypeBroad incumbent
Description

EU-level financial institution supporting European SMEs through fund-of-funds and direct VC/growth investments. Comparable as a state-backed European growth capital provider, though with a broader fund-of-funds mandate than Bpifrance Large Venture's direct-investment focus.

TypeDirect peer
Description

Italian state-backed financial institution that invests in strategic Italian companies and growth-stage ventures. Comparable as another sovereign-backed European growth investor with a national-economic mandate similar to Bpifrance's.

TypeDirect peer
Description

Global growth equity investor with a large, multi-billion-dollar fund focused on scale-up software and technology investments. Comparable as a growth-stage equity investor writing large checks in innovative technology companies.

TypeBroad incumbent
Description

Global growth equity firm making large minority investments in high-growth companies across technology and life sciences. Comparable in growth-stage mandate and capital-intensive sector focus, though privately held rather than state-backed.

TypeBroad incumbent
Description

Sovereign-backed Abu Dhabi investor deploying capital into growth-stage technology and life sciences companies globally. Comparable as another large sovereign growth investor with international reach and a multi-stage mandate.

TypeBroad incumbent
Description

Singapore state-owned investor with global growth-stage technology and life sciences allocation. Comparable as a sovereign-backed long-horizon investor in frontier innovation, though with a much broader geographic and sector mandate.

TypeEmerging player
Description

European venture capital firm specializing in healthcare and life sciences growth-stage investments. Directly comparable as a co-investor alongside Bpifrance Large Venture (e.g., Adcytherix €105M Series A) with a similar life sciences growth mandate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment14 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bpifrance Large Venture

Venture Capital / Growth Equitybpifrance.com

Bpifrance Large Venture is a €2.5 billion growth-stage venture capital fund operated within Bpifrance, France's sovereign public investment bank. It provides equity and quasi-equity financing to highly innovative technology and life sciences companies via anchors in private rounds, IPOs, and SPAC transactions.

What Bpifrance Large Venture does

Bpifrance Large Venture is a dedicated growth-stage venture capital fund operated by Bpifrance, the French public investment bank and sovereign fund wholly owned by the French State and Caisse des Dépôts. The fund invests equity and quasi-equity capital in highly innovative technology and life sciences companies, both listed and unlisted, that require large, late-stage tickets to scale internationally. It is documented with a €2.5 billion deployment size and pursues a horizontal strategy across deep tech, quantum, AI infrastructure, digital media, and biotech. Its product page explicitly positions it as the Growth arm of Bpifrance's investment continuum, providing anchor checks in private rounds, IPOs (IEVA Group on Euronext Growth Paris), and structured/SPAC transactions (Pasqal).

Bpifrance Large Venture firmographics

Firmographics
Name
Bpifrance Large Venture
Legal name
Bpifrance
Website
https://bpifrance.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Bpifrance Large Venture is a €2.5 billion growth-stage venture capital fund operated within Bpifrance, France's sovereign public investment bank. It provides equity and quasi-equity financing to highly innovative technology and life sciences companies via anchors in private rounds, IPOs, and SPAC transactions.
Ownership category
akta.pro rank

Bpifrance Large Venture industry classification

Industry
Product category
Venture Capital / Growth Equity
NAICS
Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282)
akta.pro primary industry
Growth Equity Fund-of-Funds (FSANAGAE)
akta.pro secondary industries
Venture Growth / Recurring Revenue Credit Funds (FSANAIAG), Large-Cap / Sponsor Finance Direct Lending (FSANADAJ)

Keywords

  • Venture capital
  • Growth equity
  • Technology investment
  • Life sciences investment
  • Growth fund

Where Bpifrance Large Venture is headquartered

Location

Headquarters

HQ city
Maisons-alfort
HQ country
France
HQ region
Europe

Markets served

Bpifrance Large Venture business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels2 records

Marketing channels4 records

Bpifrance Large Venture product offering

Product offering

Core offering

Bpifrance Large Venture is a €2.5 billion Growth fund providing equity and quasi-equity financing to highly innovative Technology and Life Sciences companies (both listed and unlisted), active on international markets. The fund typically acts as anchor or lead investor in significant funding rounds, IPOs (such as IEVA Group on Euronext Growth Paris), and SPAC transactions (such as Pasqal's $2 billion deal), supporting companies with high growth potential that require substantial capital to scale.

Product overview

Bpifrance Large Venture is a single focused investment fund product — a €2.5 billion Growth fund managed by Bpifrance that targets highly innovative Technology & Life Sciences companies (both listed and unlisted). The fund provides equity and quasi-equity financing to support companies with strong growth potential, often acting as an anchor or lead investor in significant funding rounds. It is part of Bpifrance's broader continuum of investment solutions but represents a distinct, named fund product aimed at later-stage innovative companies seeking to scale.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bpifrance Large Venture Fund A €2.5 billion Growth fund managed by Bpifrance that provides equity and quasi-equity investment to highly innovative Technology and Life Sciences companies (listed or unlisted) active on international markets, acting as anchor or lead investor in major funding rounds, IPOs, and SPAC transactions to support high-growth potential companies.

Companies that use Bpifrance Large Venture

Customer profile

Segments2 records

Ideal customer profiles2 records

Bpifrance Large Venture technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bpifrance Large Venture partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Bpifrance Large Venture competitors and assessment

Company assessment

Direct peers

  • KfW Capital: German state-backed venture and growth capital investor (subsidiary of KfW Group) that anchors and funds German and European growth-stage technology companies. Most directly comparable as another sovereign-backed European growth fund of similar scale and mandate to Bpifrance Large Venture.
  • British Patient Capital: UK government-backed commercial subsidiary of the British Business Bank that invests in UK growth-stage venture and venture capital funds. Comparable as a state-backed growth capital provider focused on scaling innovative companies in a major European economy.
  • EQT Growth: EQT's growth equity strategy invests in fast-growing, often technology-driven companies in the Nordic and broader European region with similar late-stage growth equity profile to Bpifrance Large Venture's mandate.
  • CDP Equity (Cassa Depositi e Prestiti): Italian state-backed financial institution that invests in strategic Italian companies and growth-stage ventures. Comparable as another sovereign-backed European growth investor with a national-economic mandate similar to Bpifrance's.
  • Insight Partners: Global growth equity investor with a large, multi-billion-dollar fund focused on scale-up software and technology investments. Comparable as a growth-stage equity investor writing large checks in innovative technology companies.

Broad incumbents

  • European Investment Fund (EIF): EU-level financial institution supporting European SMEs through fund-of-funds and direct VC/growth investments. Comparable as a state-backed European growth capital provider, though with a broader fund-of-funds mandate than Bpifrance Large Venture's direct-investment focus.
  • General Atlantic: Global growth equity firm making large minority investments in high-growth companies across technology and life sciences. Comparable in growth-stage mandate and capital-intensive sector focus, though privately held rather than state-backed.
  • Mubadala Capital Ventures: Sovereign-backed Abu Dhabi investor deploying capital into growth-stage technology and life sciences companies globally. Comparable as another large sovereign growth investor with international reach and a multi-stage mandate.
  • Temasek Holdings: Singapore state-owned investor with global growth-stage technology and life sciences allocation. Comparable as a sovereign-backed long-horizon investor in frontier innovation, though with a much broader geographic and sector mandate.

Emerging players

  • Kurma Partners: European venture capital firm specializing in healthcare and life sciences growth-stage investments. Directly comparable as a co-investor alongside Bpifrance Large Venture (e.g., Adcytherix €105M Series A) with a similar life sciences growth mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Bpifrance Large Venture social profiles

Digital presence

Bpifrance Large Venture financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bpifrance Large Venture leadership team

Management profile

Number of profiles

Bpifrance Large Venture subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Bpifrance Large Venture funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bpifrance Large Venture M&A and investment

M&A and investment

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bpifrance Large Venture

What does Bpifrance Large Venture do?

Bpifrance Large Venture is a €2.5 billion Growth fund providing equity and quasi-equity financing to highly innovative Technology and Life Sciences companies (both listed and unlisted), active on international markets. The fund typically acts as anchor or lead investor in significant funding rounds, IPOs (such as IEVA Group on Euronext Growth Paris), and SPAC transactions (such as Pasqal's $2 billion deal), supporting companies with high growth potential that require substantial capital to scale.

Is Bpifrance Large Venture a public or private company?

Bpifrance Large Venture is a public company. It is classified as state government owned and is currently operating.

When was Bpifrance Large Venture founded?

Bpifrance Large Venture was founded in 2013. It employs 11 to 50 people.

Where is Bpifrance Large Venture based?

Bpifrance Large Venture is headquartered in Maisons-alfort, France, in the Europe region.

Who are Bpifrance Large Venture's main competitors?

Direct peers on record are KfW Capital, British Patient Capital, EQT Growth, CDP Equity (Cassa Depositi e Prestiti) and Insight Partners. Broad incumbents are European Investment Fund (EIF), General Atlantic, Mubadala Capital Ventures and Temasek Holdings. Kurma Partners is listed as an emerging player.

Does Bpifrance Large Venture have an API?

No public API is recorded for Bpifrance Large Venture.

What industry is Bpifrance Large Venture in?

Bpifrance Large Venture's product category is Venture Capital / Growth Equity. Its primary akta.pro industry code is FSANAGAE, Growth Equity Fund-of-Funds, with a secondary code of FSANAIAG, Venture Growth / Recurring Revenue Credit Funds. Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
pharmaphorumBioptimus, Cancer Research Horizons partner on AI-powered precision medicineBioptimus partnered with Cancer Research Horizons to access the S:CORT colorectal cancer dataset, including over 1,750 patient profiles. The data integrates six modalities and will be added to STELA, a multimodal tissue atlas. Bioptimus has raised $76 million since its February 2024 founding.MaddynessLe fonds Growth de Bpifrance change de têteCharlotte Corbaz has been appointed director of Bpifrance Large Venture, the French sovereign growth fund, succeeding Maïlys Ferrère who led the vehicle since its creation in 2013. The fund manages €2.5 billion in assets across 62 portfolio companies, having deployed €2 billion through 85 investments and representing nearly 30% of French unicorns. While the investment strategy remains unchanged, the article notes the growth market has shifted toward profitability focus, with Large Venture developing 'VC to PE' transition strategies to support companies near financial equilibrium.InvenTop 15 Marine Engine Manufacturing Investors in EuropeInven published a curated list of the top 15 investors active in the European marine engine manufacturing sector, highlighting firms such as Bpifrance French Tech Accélération, the European Innovation Council, and InnoEnergy. The report details significant transactions by these entities, including investments in electric propulsion startups like Evoy and Corvus Energy, as well as acquisitions of established manufacturers like Steyr Motors and MacGregor. This data reflects a growing capital influx into sustainable maritime technologies and decarbonization efforts within the industry.FinSMEsGecko Biomedical Raises €1.3M in FundingGecko Biomedical, a Paris-based medical device company, raised €1.3M from Bpifrance. The funds will advance manufacturing scale-up of its Liquid Film platform and complete non-clinical development for regulatory purposes. The company, founded in 2013, focuses on biodegradable surgical glues and patches.GlobeNewswireDGAP-News: Poxel Raises EUR10 Million from New Investors to Progress Clinical Development of Two Novel Type 2 Diabetes TherapiesPoxel raised EUR10 million from Bpifrance and Kreos Capital, bringing its Series B to EUR18 million. The funds will accelerate Imeglimin's phase IIb trial and a direct AMPK activator program. Phase IIb results are expected in 2015.